One-pot protein screening accelerates bioscience and drug discovery
Machine learning and supercomputing have brought about a revolution in computational drug discovery. More therapeutic candidates, like antibodies that bind to and fight the SARS-CoV-2 virus, can be explored and simulated than ever before. But for practical, safe use, these computational candidates must be grounded in experimental validation.
Machine learning and supercomputing have brought about a revolution in computational drug discovery. More therapeutic candidates, like antibodies that bind to and fight the SARS-CoV-2 virus, can be explored and simulated than ever before. But for practical, safe use, these computational candidates must be grounded in experimental validation.
